KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Receivables (2016 - 2025)

Historic Receivables for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $1.3 billion.

  • Biogen's Receivables fell 444.19% to $1.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.3 billion, marking a year-over-year decrease of 444.19%. This contributed to the annual value of $1.3 billion for FY2025, which is 444.19% down from last year.
  • Biogen's Receivables amounted to $1.3 billion in Q4 2025, which was down 444.19% from $4.8 million recorded in Q3 2025.
  • In the past 5 years, Biogen's Receivables registered a high of $2.0 billion during Q1 2022, and its lowest value of $3.9 million during Q1 2025.
  • In the last 5 years, Biogen's Receivables had a median value of $1.7 billion in 2022 and averaged $1.4 billion.
  • In the last 5 years, Biogen's Receivables soared by 972.87% in 2022 and then crashed by 9969.27% in 2025.
  • Over the past 5 years, Biogen's Receivables (Quarter) stood at $1.8 billion in 2021, then decreased by 6.97% to $1.7 billion in 2022, then decreased by 2.51% to $1.7 billion in 2023, then dropped by 15.58% to $1.4 billion in 2024, then fell by 4.44% to $1.3 billion in 2025.
  • Its Receivables stands at $1.3 billion for Q4 2025, versus $4.8 million for Q3 2025 and $5.0 million for Q2 2025.